Entecavir

6H-Purin-6-one,2-amino-1,9-dihydro-9- [(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl] -monohydrate
Molecular Weight	295.30
Empiric Formula	C₁₂H₁₅N₅O₃·H₂O
ATC code
Metabolism
Pregnancy category

Entecavir (commercial name Baraclude) is an oral antiviral drug discovered at the pharmaceutical company Bristol-Myers Squibb; it is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process.

This drug has been accepted by the US FDA in March 2005; it is more efficient than an older Hepatitis B drug, lamivudine.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Categories: Pharmacology stubs | Antivirals